• Advertise
  • Contact Us
  • About Us
  • Supplier Directory
  • SCB YouTube
  • Login
  • Subscribe
  • Logout
  • My Profile
  • LOGISTICS
    • Air Cargo
    • All Logistics
    • Express/Small Shipments
    • Facility Location Planning
    • Freight Forwarding/Customs Brokerage
    • Global Gateways
    • Global Logistics
    • Last Mile Delivery
    • Logistics Outsourcing
    • LTL/Truckload Services
    • Ocean Transportation
    • Rail & Intermodal
    • Reverse Logistics
    • Service Parts Management
    • Transportation & Distribution
  • TECHNOLOGY
    • All Technology
    • Artificial Intelligence
    • Cloud & On-Demand Systems
    • Data Management (Big Data/IoT/Blockchain)
    • ERP & Enterprise Systems
    • Forecasting & Demand Planning
    • Global Trade Management
    • Inventory Planning/ Optimization
    • Product Lifecycle Management
    • Sales & Operations Planning
    • SC Finance & Revenue Management
    • SC Planning & Optimization
    • Sourcing/Procurement/SRM
    • Supply Chain Visibility
    • Transportation Management
  • GENERAL SCM
    • Business Strategy Alignment
    • Education & Professional Development
    • Global Supply Chain Management
    • Global Trade & Economics
    • HR & Labor Management
    • Quality & Metrics
    • Regulation & Compliance
    • SC Security & Risk Mgmt
    • Supply Chains in Crisis
    • Sustainability & Corporate Social Responsibility
  • WAREHOUSING
    • All Warehouse Services
    • Conveyors & Sortation
    • Lift Trucks & AGVs
    • Order Fulfillment
    • Packaging
    • RFID, Barcode, Mobility & Voice
    • Robotics
    • Warehouse Management Systems
  • INDUSTRIES
    • Aerospace & Defense
    • Apparel
    • Automotive
    • Chemicals & Energy
    • Consumer Packaged Goods
    • E-Commerce/Omni-Channel
    • Food & Beverage
    • Healthcare
    • High-Tech/Electronics
    • Industrial Manufacturing
    • Pharmaceutical/Biotech
    • Retail
  • THINK TANK
  • WEBINARS
    • On-Demand Webinars
    • Upcoming Webinars
    • Webinar Library
  • PODCASTS
  • VIDEOS
  • WHITEPAPERS
Home » Carcinogen in Zantac and Generics Triggers FDA, EU Probes

Carcinogen in Zantac and Generics Triggers FDA, EU Probes

Carcinogen in Zantac and Generics Triggers FDA, EU Probes
September 17, 2019
Bloomberg

Global health regulators sounded a coordinated alarm about the possibility that a stomach drug taken by millions of people could be tainted with the same cancer-causing agent that has sparked a worldwide recall of blood-pressure pills.

Drug-safety officials in the U.S. and Europe said Friday that they were looking into whether Sanofi heartburn medication Zantac and generic versions made by numerous manufacturers contain levels of the probable carcinogen NDMA that could pose a danger to patients.

Ranitidine, as the drug is known in generic form, is an antacid and antihistamine used to treat and prevent a range of gastrointestinal disorders. The chemical NDMA, or N-Nitrosodimethylamine, is a likely human carcinogen found in cooked or cured meats such as bacon, and is a common industrial byproduct.

The discovery further underscores the challenge pharmaceutical-industry regulators face in overseeing a vast global supply chain of drugs, drug ingredients and factory processes. Dozens of versions of the hypertension treatment valsartan have been recalled since last year out of concern they could be contaminated with NDMA.

Many of those drugs were made in China or India, raising questions about the quality of generic manufacturing in far-flung factories around the globe. Bloomberg News has reported on how poor quality controls and efforts to conceal manufacturing problems from the FDA have complicated oversight of overseas drug producers.

“Sanofi takes patient safety seriously, and we are committed to working with the FDA,” Ashleigh Koss, a spokeswoman for the company, said in an email. Zantac is made in Mexico and Sanofi sources its active ingredient from Spain, Koss said.

The review of ranitidine comes after Valisure, a New Haven, Connecticut-based online pharmacy that tests all the medications it dispenses, alerted the U.S. Food and Drug Administration that it had detected high levels of NDMA in both generic and brand versions of Zantac sold at major pharmacies run by companies including Walgreens Boots Alliance Inc., CVS Health Corp. and Walmart Inc.

The FDA said in a statement Friday it would review branded and generic versions of the medication. The European Medicines Agency said it “is evaluating the data to assess whether patients using ranitidine are at any risk from NDMA and will provide information about this as soon as it is available.”

The FDA detected NDMA in both prescription and over-the-counter versions of Zantac but hasn’t collected enough samples to give a range of carcinogen levels found, Janet Woodcock, director of FDA’s Center for Drug Evaluation and Research, said in an interview. FDA and European regulators use different testing methods than Valisure, she said, but declined to give details.

Valisure filed a petition with the FDA on Friday asking the agency to recall Zantac and its generics that contain NDMA. The FDA said the NDMA levels in the drugs are low, while Valisure’s petition called them excessive.

“We don’t think this poses an immediate hazard to human health so we’ll have an ongoing process to determine whether recalls are needed,” Woodcock said.

Inherently Present

The FDA didn’t recommend people who take Zantac or its generics stop taking it but advised that other medications are available.

Once international regulators agree on NDMA testing methods for the drugs, the agency will ask manufacturers to test their versions of Zantac, Woodcock said. The agency will also seek samples from manufacturers to test itself and expects it will take a couple weeks to get more information, Woodcock said.

The FDA doesn’t know how NDMA got into the drugs but its preliminary hypothesis is that it is different from the manufacturing process for the blood-pressure pills that are also tainted, agency spokesman Jeremy Kahn said in an email.

Valisure Chief Executive Officer David Light said his company thinks NDMA is inherently present in Zantac. A Stanford University study was done in 2016 based on a similar understanding.

Stanford environmental researchers interested in how NDMA forms at low levels in wastewater measured levels of the carcinogen in the urine of 10 volunteers who took ranitidine. They found that NDMA levels rose 400-fold after volunteers took the drug, to 48 micrograms — nearly triple the 17 micrograms the FDA found in some recalled blood-pressure pills.

The scientists said in their research that the risks of ranitidine should be evaluated.

“We’re not in that field so we basically left it at that,” William Mitch, one of the Stanford researchers, said in an interview. “We put it out as food for thought hoping someone would pick it up.”

Research Effort

Researchers at the Memorial Sloan Kettering Cancer Center are also looking into whether NDMA levels in generic and brand-name Zantac may be linked to an increased risk of cancer based on the findings shared by Valisure, said Lior Braunstein, an oncologist at Sloan Kettering who is co-leading the research on Zantac.

Zantac and its generics are sold with and without a prescription in different strengths. Almost 25 million prescriptions for the drugs were written in 2018, according to Bloomberg Intelligence data.

“There’s no acceptable cancer risk for a drug like this,” Valisure CEO Light said.

Zantac isn’t just taken by adults. It is also given to infants suffering from reflux in a syrup form that requires a prescription.

The FDA found NDMA levels as high as 17 micrograms in blood-pressure pills recalled starting in July 2018. Valisure detected NDMA levels as high as 3,000 micrograms in Zantac pills and its generics. In the wake of recalls of blood-pressure drugs, the FDA set an NDMA limit of less than one microgram for the pills and required all companies that make the hypertension treatments to test for the contaminant.

RELATED CONTENT

RELATED VIDEOS

Sourcing/Procurement/SRM Supply Chain Visibility Global Supply Chain Management Quality & Metrics Regulation & Compliance Supply Chain Security & Risk Mgmt Healthcare Pharmaceutical/Biotech
KEYWORDS Asia Pacific China Europe healthcare North America Pharmaceutical/Biotech Quality & Metrics Regulation & Compliance SC Security & Risk Mgmt Sourcing/Procurement/SRM Supply Chain Visibility
Bloomberg

Biden’s Antitrust Push Across Agencies Is Working to Block Deals

More from this author

Subscribe to our Daily Newsletter!

Timely, incisive articles delivered directly to your inbox.

Popular Stories

  • A GIANT EXCAVATOR BEARING THE JOHN DEERE LOGO SITS IN A FIELD IN DAPPLED SUNLIGHT

    EVs Finally Land at North America’s Biggest Machinery Conference

    Technology
  • A ROW OF HOT AIR BALLOONS CONTAINS A ROCKET ZOOMING PAST THEM

    When Adopting New Tools for the Supply Chain, Don’t Forget Change Management

    Technology
  • A mature male architect stands with his arms crossed at a building site

    Biden Wants American-Made Construction Materials. Is That Feasible?

    Sourcing/Procurement/SRM
  • DEEPLY CRACKED EARTH UNDER A BLUE CLOUDY SKY

    It’s Time to Embed Climate Considerations Into Supply Chain Strategies

    Sourcing/Procurement/SRM
  • TWO HANDS IN SHIRT CUFFS SHAKE AGAINST A BACKGROUND OF A US FLAG

    Podcast | Leaving China: Is ‘Friend-Shoring’ the Answer?

    Sourcing/Procurement/SRM

Digital Edition

Scb q1 2023 cover

2023 Supply Chain Management Resource Guide: Packing for a Difficult Year

VIEW THE LATEST ISSUE

Case Studies

  • New Revenue for Cloud-Based TMS that Embeds Orderful’s Modern EDI Platform

  • Convenience Store Client Maximizes Profit and Improves Customer Service

  • A Digitally Native Footwear Brand Finds Rapid Fulfillment

  • Expanding Apparel Brand Scales Seamlessly with E-Commerce Technology

  • How a Global LSP Scaled its Security Program and Won More Business

Visit Our Sponsors

Orderful Yang Ming Alithya
Barcoding Blue Yonder BNSF Logistics
CoEnterprise Data Capture Deposco
E2open GAINSystems Generix
Geodis GEP GreyOrange
Here Holman Logistics Honeywell Intelligrated
IFM Infor Inmar
Keelvar Kinaxis Korber
Lean Solutions Group 2H Liberty SBF Locus Robotics
Logility LogistiVIEW Lucas Systems
MCA Connect MPO Nvidia
Old Dominion OpenText ORTEC
Overhaul Parsyl PMMI
QIMA Redwood Logistics Ryder E-commerce by Whiplash
Saddle Creek Logistics Schneider Dedicated Setlog Holding AG
Ship4WD Shipwell Shyft
Sourcemap Tecsys TGW Systems
Thomson Reuters Tive Trailer Bridge
Vecna Robotics Verity
Verusen
  • More From SCB
    • Featured Content
    • Video Library
    • Think Tank Blog
    • SupplyChainBrain Podcast
    • Whitepapers
    • On-Demand Webinars
    • Upcoming Webinars
  • Digital Offerings
    • Digital Issue
    • Subscribe
    • Manage Your Subscription
    • Newsletters
  • Resources
    • Events Calendar
    • SCB's Great Supply Chain Partners
    • Supplier Directory
    • Case Study Showcase
    • Supply Chain Innovation Awards
    • 100 Great Partners Form
  • SCB Corporate
    • Advertise on SCB.COM
    • About Us
    • Privacy Policy
    • Contact Us
    • Data Sharing Opt-Out

All content copyright ©2023 Keller International Publishing Corp All rights reserved. No reproduction, transmission or display is permitted without the written permissions of Keller International Publishing Corp

Design, CMS, Hosting & Web Development :: ePublishing